HCAT SCHEDULE 13D/A: Activist campaign

Palogic Value Fund, LP and Palogic Value Management, LP

Filed with the SEC on · accession 0001104659-26-105948

HCAT filed a SCHEDULE 13D/A (schedule 13d/a) with the SEC on Sep 8, 2026. A report the company filed with the SEC (the US market regulator). The stock moved +0.6% by the first close after the filing.

Summary of the filing

Palogic Value Fund, LP and Palogic Value Management, LP reported additional open market purchases of Health Catalyst common stock between August 6 and September 1, 2026, acquiring approximately 451,720 shares at prices ranging from $1.53 to $1.76 per share.

Key details

Total shares acquired in reported transactionsshares 452K
Price per share range$2
Reporting person / shareholderPalogic Value Fund, LP
Reporting person / shareholderPalogic Value Management, LP
IssuerHealth Catalyst, Inc.

How HCAT stock reacted

Close before

$1.69

Sep 4, 2026

First close after

+0.59%

$1.70

5 trading days

+7.69%

$1.82

Since filing

-11.24%

$1.50

✦ Ask GOAX AI about this filing — what it means for HCAT, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for HCAT?

Click here

Frequently asked questions

What did HCAT file with the SEC on Sep 8, 2026?

HCAT filed a SCHEDULE 13D/A (Activist campaign). Palogic Value Fund, LP and Palogic Value Management, LP reported additional open market purchases of Health Catalyst common stock between August 6 and September 1, 2026, acquiring approximately 451,720 shares at prices ranging from $1.53 to $1.76 per share.

What does a activist campaign mean for HCAT stock?

A settlement removes uncertainty; the stock often reacts to whether the amount is bigger or smaller than investors expected.

How do I read a SCHEDULE 13D/A?

A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13D/A (schedule 13d/a): A report the company filed with the SEC (the US market regulator).

How did HCAT stock react to this filing?

HCAT closed at $1.69 before the filing and $1.70 on Sep 8, 2026 (+0.59%). Five trading days later: $1.82 (+7.69%).

Other HCAT SEC filings

Get alerts when HCAT files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days